Opal Biosciences Annual Report 2016
Opal Biosciences Notice of Meeting and proxy form 2016
For more information, visit www.opalbiosciences.com
Infectious disease therapy and vaccine development company BioDiem Ltd and its subsidiary company Opal Biosciences Ltd (“Opal”) are pleased to provide the following information.
Opal Biosciences Limited announces its Information Memorandum